Dr. Surendra Varma Appointed to Texas Medical Board District Three Review Committee

Translate to Spanish or other 102 languages!

Governor Greg Abbott has appointed Surendra Varma, M.D. to the Texas Medical Board (TMB) District Three Review Committee for a term set to expire on January 15, 2026. Image source: Facebook
Governor Greg Abbott has appointed Surendra Varma, M.D. to the Texas Medical Board (TMB) District Three Review Committee for a term set to expire on January 15, 2026. Image source: Facebook
- Advertisement -

AUSTIN – Governor Greg Abbott has appointed Surendra Varma, M.D. to the Texas Medical Board (TMB) District Three Review Committee for a term set to expire on January 15, 2026.

Surendra Varma, M.D. of Lubbock is the executive associate dean for graduate medical education at the Texas Tech University Health Sciences Center (TTUHSC) and is a Grover E. Murray Professor and Ted Hartman Endowed Chair in Medical Education at TTUHSC. He is an associate editor for Advances in Pediatrics, editorial board member for the Journal of Clinical Endocrinology and Metabolism, and a member of the American Pediatric Society, Society for Pediatric Research, Endocrine Society, and the Council on Graduate Medical Education for the Health Resources & Services Administration. He is a member and former president of the American Diabetes Association and a member and former Texas affiliate chair of endocrinology for the American Academy of Pediatrics. Previously, he served as a gubernatorial appointee on the TMB District Three Review Committee for six years, TMB for five years, and the Task Force on Infectious Disease Preparedness and Response for four years. Varma received a Bachelor of Science in Physics, Chemistry, Biology and English from the University of Lucknow, and a Bachelor of Medicine, a Bachelor of Surgery, and a Doctor of Medicine in Pediatrics from King George Medical University (KGMU). He has received honorary Doctorate (DSc) from KGMU and Honorary Fellowship (FRCP) from Royal College of Physicians. 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Expands Kidney Transplant Program with Transplant Nephrologist, Dr. Victor E. Prado

As part of its ongoing commitment to bringing world-class healthcare to the Rio Grande Valley, DHR Health is pleased to announce the addition of double board-certified transplant nephrologist, Dr. Victor E. Prado. Dr. Prado will provide care to patients at DHR Health’s Transplant Institute,

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.

HHS Opens $1 Million Funding Opportunity to Strengthen Women’s Preventive Care

The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), announced a Notice of Funding Opportunity (NOFO) for the Women’s Initiative for Screening and Health (WISH) program.
- Advertisement -